COMPLIX
Complix is a biopharmaceutical company focused on the discovery and development of Alphabodiesâ„¢, a novel class of biopharmaceuticals that offer significant advantages over existing protein based therapies. Alphabodiesâ„¢ bind with high affinity to a wide range of disease targets and are particularly suited to address certain targets that are difficult to reach with antibodies or other types of protein scaffolds. Due to their unique stability and versatility Alphabodiesâ„¢ can be delivered via alternative non-injectable routes of administration, unlike most therapeutic proteins.
COMPLIX
Industry:
Biotechnology Health Care Therapeutics
Founded:
2008-01-01
Address:
Diepenbeek, Limburg, Belgium
Country:
Belgium
Website Url:
http://www.complix.com
Total Employee:
11+
Status:
Active
Contact:
32 9 241 57 15
Total Funding:
26.59 M USD
Technology used in webpage:
Facebook Sharer 3 To 9 CcTLD Redirects
Current Advisors List
Board_member
2015-07-01
Board_observer
Current Employees Featured
Mark Vaeck Co-Founder & CEO @ Complix
Co-Founder & CEO
2010-05-01
Ignace Lasters CTO @ Complix
CTO
Founder
Investors List
Agentschap Innoveren & Ondernemen
Agentschap Innoveren & Ondernemen investment in Grant - Complix
Flanders Innovation and Entrepreneurship (VLAIO)
Flanders Innovation and Entrepreneurship (VLAIO) investment in Grant - Complix
Baekeland Funds
Baekeland Funds investment in Series B - Complix
Andera Partners
Andera Partners investment in Series B - Complix
Gimv
Gimv investment in Series B - Complix
Vinnof
Vinnof investment in Series B - Complix
Vesalius Biocapital Partners
Vesalius Biocapital Partners investment in Series B - Complix
Limburgse Reconversie Maatschappij
Limburgse Reconversie Maatschappij investment in Series B - Complix
Gemma Frisius Fund
Gemma Frisius Fund investment in Series B - Complix
TrustCapital
TrustCapital investment in Series B - Complix
Official Site Inspections
http://www.complix.com Semrush global rank: 6.23 M Semrush visits lastest month: 1.24 K
- Host name: linweb504.webhosting.be
- IP address: 5.134.6.54
- Location: Gouvy Belgium
- Latitude: 50.186
- Longitude: 5.9392
- Timezone: Europe/Brussels
- Postal: 6670
More informations about "Complix"
Complix - Crunchbase Company Profile & Funding
Organization. Complix . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Complix is a …See details»
About us - Complix
Mar 10, 2021 Complix’s goal is to use its unique Alphabody technology to develop transformative biotherapeutics for applications in viral diseases, oncology, immuno-oncology and autoimmunity, which are large therapeutic …See details»
Complix | Cell Penetrating Alphabodies
Complix’s proprietary Cell Penetrating Alphabody (CPAB) technology allows it to access intracellular targets that are considered intractable by current drug formats. Moreover Alphabodies can effectively address therapeutic targets …See details»
Management - Complix
Jul 28, 2021 In 2008, he co-founded Complix and was appointed CEO in May 2010. Prior to this, in 2006, Mark co-founded ActoGeniX (Belgium) and served as its CEO until 2010. He was also the founding CEO of Ablynx (Belgium) from …See details»
Complix N.V. - LinkedIn
Complix N.V. Biotechnology Research Complix is a biopharmaceutical company leading the way in the use of biologics for challenging disease targets.See details»
Complix Company Profile | Management and Employees List
Complix Profile and History. Complix is a biopharmaceutical company using its unique AlphabodyTM platform to develop a pipeline of transformative, "membrane crossing" …See details»
Complix Company Profile - Office Locations, Competitors ... - Craft
Complix is a biopharmaceutical company dedicated to the discovery and development of protein therapeutics for pharmaceutical and medical device applications using its alpha-body …See details»
Complix 2025 Company Profile: Valuation, Funding
Complix General Information Description. Operator of a biopharmaceutical company intended to target intractable or challenging disease targets. The company is developing a transformative pipeline of alpha body therapeutics …See details»
Complix - VentureRadar
Complix is a biopharmaceutical company focused on the discovery and development of Alphabodies, a novel class of biopharmaceuticals that offer significant advantages over …See details»
Complix - Funding, Financials, Valuation & Investors - Crunchbase
Complix is a biopharmaceutical company developing Alphabodies, a novel class of biopharmaceuticals. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. …See details»
Complix - Contacts, Employees, Board Members, Advisors & Alumni
Organization. Complix . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies ... and Advisor Profiles 2. Contacts 12. About. Complix …See details»
Complix | Board of directors
Complix is a biopharmaceutical company developing a pipeline of transformative Alphabody based therapeutics against a number of cutting-edge and challenging disease targets that play …See details»
OPSCOMPLIX
Your Partner in Operations and Compliance Excellence. Optimize, streamline, and enhance your organization’s operations. Ensure compliance with ISO standards, GDPR, and ESG-related …See details»
Complix - Overview, News & Similar companies | ZoomInfo.com
Who is Complix. Complix is a biopharmaceutical company using its unique AlphabodyTM platform to develop a pipeline of transformative, "membrane crossing" therapeut ics against a number …See details»
Complix Company Information - Funding, Investors, and More
Get information on funding, investors, industries, and more for Complix. See Complix company profile and funding data.See details»
Home | CompliX
CompliX is a provider of niche software that helps organisations fight financial crime intelligently and proactively. We provide next generation software solutions that enables Financial Crime …See details»
Complix | Complix Enters into Strategic Collaboration with Merck …
Hasselt, Belgium, January 6 2016 – Complix, a biopharmaceutical company developing a pipeline of transformative protein therapeutics, called Alphabodies™, for the treatment of cancer and …See details»
About CompliX | Experts in Financial Crime Compliance Solutions
CompliX is a provider of niche software that helps organisations fight financial crime intelligently and proactively. We provide next generation software solutions that enables Financial Crime …See details»
Complix | News
Complix is a biopharmaceutical company developing a pipeline of transformative Cell Penetrating Alphabody (CPAB) based biotherapeutics active against cutting-edge and challenging …See details»
Pipeline - Complix
Mar 10, 2021 Complix has an ongoing anti-Covid-19 drug discovery campaign that builds on its vast experience in the design of anti-viral compounds. By targeting the highly conserved alpha …See details»